SCHEMBL6087802

SCHEMBL6087802

OC1=C(C2CCCC2)c2nc(Nc3ccccc3)ncc2CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 4/20 0.57
CDK2 P24941 15/20 0.55
CCNA2 P20248 12/20 0.55
CCNA1 P78396 8/20 0.50
AURKA O14965 5/20 0.50
PLK1 P53350 4/20 0.50
CDK5 Q00535 1/20 0.50
CDK5R1 Q15078 1/20 0.50
CDK4 P11802 4/20 0.49
CDK1 P06493 3/20 0.49
CCNB1 P14635 3/20 0.49
CCND1 P24385 3/20 0.49
CCNE1 P24864 3/20 0.49
CCNT1 O60563 2/20 0.49
CDK7 P50613 2/20 0.49
CDK9 P50750 2/20 0.49
CCNH P51946 2/20 0.49
CCND3 P30281 1/20 0.46
TTK P33981 1/20 0.46
CDK6 Q00534 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6087509 0.89 IGF1R (0.46) IGF1RCDK2CCNA2CCNA1AURKA
SCHEMBL6089542 0.84 CDK4 (0.51) IGF1RCDK2CCNA2CCNA1AURKA
SCHEMBL6087080 0.83 IGF1R (0.58) IGF1RCDK2CCNA2CCNA1AURKA
SCHEMBL6086831 0.81 CDK4 (0.61) CDK2CCNA2CCNA1CDK4CDK1
SCHEMBL6087322 0.80 CDK2 (0.44) IGF1RCDK2CCNA2AURKACDK4
SCHEMBL6087397 0.79 IGF1R (0.46) IGF1RCDK2CCNA2CCNA1AURKA
SCHEMBL6088186 0.79 CDK4 (0.55) IGF1RCDK2CCNA2CCNA1AURKA
SCHEMBL6086771 0.79 CDK2 (0.56) IGF1RCDK2CCNA2CCNA1AURKA
SCHEMBL6087387 0.78 CDK4 (0.59) CDK2CCNA2AURKACDK4CCND1
SCHEMBL7475319 0.77 CDK2 (0.46) IGF1RCDK2CCNA2CCNA1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP claimed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO claimed
US-6982260-B1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes WARNER-LAMBERT COMPANY (US) 2006-01-03 US disclosed
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO disclosed